April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Identification of Novel Loci for Diabetic Retinopathy in European Americans: The Family Investigation of Nephropathy and Diabetes (FIND)
Sudha K. Iyengar; Y-D Ida Chen; Emily Y. Chew; Robert P. Igo, Jr.; Robert G. Nelson; Ronald P. Danis; Barry I. Freedman; John R. Sedor; Jerome I. Rotter; FIND Consortium
Author Affiliations & Notes
  • Sudha K. Iyengar
    Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • Y-D Ida Chen
    Medical Genetics Research Institute, Cedars Sinai Medical Center, Los Angeles, California
  • Emily Y. Chew
    Division of Epidemiology and Clinical Applications, National Eye Institute, Bethesda, Maryland
  • Robert P. Igo, Jr.
    Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • Robert G. Nelson
    Phoenix Epidemiology and Clinical Research Branch, NIDDK, National Institutes of Health, Phoenix, Arizona
  • Ronald P. Danis
    Department of Ophthalmology & Visual Sciences, University of Wisconsin, Madison, Wisconsin
  • Barry I. Freedman
    Nephrology, Wake Forest University, Wisnton Salem, North Carolina
  • John R. Sedor
    Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • Jerome I. Rotter
    Medical Genetics Research Institute, Cedars Sinai Medical Center, Los Angeles, California
  • FIND Consortium
    Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Sudha K. Iyengar, None; Y-D Ida Chen, None; Emily Y. Chew, None; Robert P. Igo, Jr., None; Robert G. Nelson, None; Ronald P. Danis, None; Barry I. Freedman, None; John R. Sedor, None; Jerome I. Rotter, None
  • Footnotes
    Support  NIDDK grant U01DK057292
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Identification of Novel Loci for Diabetic Retinopathy in European Americans: The Family Investigation of Nephropathy and Diabetes (FIND)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Sudha K. Iyengar, Y-D Ida Chen, Emily Y. Chew, Robert P. Igo, Jr., Robert G. Nelson, Ronald P. Danis, Barry I. Freedman, John R. Sedor, Jerome I. Rotter, FIND Consortium; Identification of Novel Loci for Diabetic Retinopathy in European Americans: The Family Investigation of Nephropathy and Diabetes (FIND). Invest. Ophthalmol. Vis. Sci. 2011;52(14):4820.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : Diabetic Retinopathy (DR) is a common microvascular complication of type 1 and 2 diabetes mellitus (DM). It affects over 60% of diabetic individuals, and is a leading cause of visual impairment. DR ranges in severity from mild/moderate non-proliferative disease to proliferative disease, and is often accompanied by macular edema. In the hopes of gaining insights into DR susceptibility, we conducted a genome-wide association study (GWAS) in a European American sample with and without DR.

Methods: : In FIND, participants had ophthalmological exams and stereoscopic seven-field retinal photos graded, and assessed according to the methods of the Early Treatment Diabetic Retinopathy Study Group (ETDRS). DNA from participants was genotyped using the Affymetrix 6.0 chip with ~ 950,000 markers, imputed to >2.4 million markers. Logistic regression was used to contrast cases with DR (N=105) versus controls (N = 627) who were disease free, adjusting for the effects of sex, study center, DM duration, and two principal components for population structure. Glycosylated hemoglobin was examined as a covariate, but not included because it was not significant.

Results: : The best p-value was on chromosome 20 at rs2425644 (Odds Ratio = 3.0; p = 1.2 x 10-7) within the serine incorporator 3 locus (SERINC3). SERINC3 is a transmembrane protein whose function has not been well characterized. In addition to SERINC3, several other loci with similar evidence on chromosomes 2, 3, 4, 5 and 14 were also observed. Genotyped and imputed markers in previously reported candidate genes such as EPO, VEGFA and its receptor KDR showed no association at p<0.05.

Conclusions: : Our analysis has identified several novel loci for DR that may provide insights into DR etiology. We are pursuing replication of these results in additional samples in order to provide better support for these findings.

Keywords: diabetic retinopathy • genetics • clinical (human) or epidemiologic studies: outcomes/complications 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept